BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6237852)

  • 21. Prolactin release in polycystic ovary.
    Falaschi P; del Pozo E; Rocco A; Toscano V; Petrangeli E; Pompei P; Frajese G
    Obstet Gynecol; 1980 May; 55(5):579-82. PubMed ID: 6768043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS.
    Uncu G; Sözer MC; Develioğlu O; Cengiz C
    Gynecol Endocrinol; 2002 Dec; 16(6):447-52. PubMed ID: 12626031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An update on Stein-Leventhal syndrome.
    Barnett DC
    Issues Health Care Women; 1980; 2(5-6):25-30. PubMed ID: 6795253
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pathophysiology and diagnosis of polycystic ovary syndrome].
    Bouchard P
    J Gynecol Obstet Biol Reprod (Paris); 2003; 32(3 Pt 2):S5-10. PubMed ID: 12773912
    [No Abstract]   [Full Text] [Related]  

  • 25. [The Stein-Leventhal syndrome. Clinical, biological and anatomic study of 6 cases in adolescent girls (author's transl)].
    Petrus M; Claverie J; Vancina S; Becue J; Dutau G; Rochiccioli P
    Arch Fr Pediatr; 1981; 38(6):417-22. PubMed ID: 6794535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of spironolactone on testosterone and LHRH responsiveness in women with polycystic ovarian disease.
    Evron S; Yosef SM; Schenker JG; Diamant YZ
    Isr J Med Sci; 1984 Jul; 20(7):630-3. PubMed ID: 6432730
    [No Abstract]   [Full Text] [Related]  

  • 27. Polycystic ovary syndrome.
    Ginsburg J; Havard CW
    Br Med J; 1976 Sep; 2(6038):737-40. PubMed ID: 788846
    [No Abstract]   [Full Text] [Related]  

  • 28. Thecosis.
    Fienberg R
    Pathol Annu; 1981; 16(Pt 2):239-71. PubMed ID: 7036061
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for the hypothalamic origin of the polycystic ovary syndrome.
    Wortsman J; Singh KB; Murphy J
    Obstet Gynecol; 1981 Aug; 58(2):137-41. PubMed ID: 6454866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects.
    Seow KM; Juan CC; Hwang JL; Ho LT
    Semin Reprod Med; 2008 Jan; 26(1):101-10. PubMed ID: 18181088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.
    Naessén S; Carlström K; Garoff L; Glant R; Hirschberg AL
    Gynecol Endocrinol; 2006 Jul; 22(7):388-94. PubMed ID: 16864149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of laparoscopic ovarian diathermy on circulating inhibin B in women with anovulatory polycystic ovary syndrome.
    Hendriks ML; Lambalk CB
    Hum Reprod; 2007 Jul; 22(7):2073; author reply 2073-4. PubMed ID: 17525068
    [No Abstract]   [Full Text] [Related]  

  • 34. [Estrone, estradiol and estriol content after intravaginal application of estriol in postmenopause].
    Keller PJ; Riedmann R; Fischer M
    Gynakol Rundsch; 1980 Jun; 20 Suppl 1():77-9. PubMed ID: 6783486
    [No Abstract]   [Full Text] [Related]  

  • 35. Interstitial cell tumor of the testis in adults: two case reports.
    Selvaggi FP; Young RT; Brown R; Dick AL
    J Urol; 1973 Mar; 109(3):436-9. PubMed ID: 4692379
    [No Abstract]   [Full Text] [Related]  

  • 36. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics.
    La Marca A; Orvieto R; Giulini S; Jasonni VM; Volpe A; De Leo V
    Fertil Steril; 2004 Oct; 82(4):970-2. PubMed ID: 15482785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tyrosine phosphorylation and protein expression of insulin receptor substrate-1 in the patients with polycystic ovary syndrome].
    Chu YL; Sun YY; Qiu HY; Li HF
    Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):176-9. PubMed ID: 15130378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do basal inhibin A and inhibin B levels have value in the diagnosis of polycystic ovary syndrome?
    Torgac M; Kokcu A; Cetinkaya MB; Alper T; Malatyalioglu E
    Gynecol Endocrinol; 2005 Jun; 20(6):322-6. PubMed ID: 16019381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Round table conference: current topics in endocrinology].
    Shizume K; Kumahara Y; Ibayashi H; Nakayama T; Ogata E
    Naika; 1971; 28(1):84-104. PubMed ID: 4327704
    [No Abstract]   [Full Text] [Related]  

  • 40. Saliva as a matrix for measuring free androgens: comparison with serum androgens in polycystic ovarian disease.
    Smith RG; Besch PK; Dill B; Buttram VC
    Fertil Steril; 1979 May; 31(5):513-7. PubMed ID: 156132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.